المؤلفون: Naci, Huseyin, Davis, Courtney, Savović, Jelena, Higgins, Julian P T, Sterne, Jonathan A C, Gyawali, Bishal, Romo-Sandoval, Xochitl, Handley, Nicola, Booth, Christopher M

المصدر: BMJ: British Medical Journal, 2019 Sep . 366, 1-17.

URL الوصول: https://www.jstor.org/stable/27177830

المؤلفون: Naci, Huseyin, Davis, Courtney, Savović, Jelena, Higgins, Julian P T, Sterne, Jonathan, Gyawali, Bishal, Romo-Sandoval, Xochitl, Handley, Nicola, Booth, Christopher M

المصدر: Naci, H, Davis, C, Savović, J, Higgins, J P T, Sterne, J, Gyawali, B, Romo-Sandoval, X, Handley, N & Booth, C M 2019, ' Design characteristics, risk of bias, and reporting of randomised controlled trials supporting European Medicines Agency approvals of cancer drugs, 2014-2016 : Cross-sectional analysis ', BMJ, vol. 366, l5221 . https://doi.org/10.1136/bmj.l5221

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______2642::70525d3037c6fdf4763adc44082601c3
https://research-information.bris.ac.uk/ws/files/211495046/bmj.l5221.full.pdf

المؤلفون: Naci H; Department of Health Policy, London School of Economics and Political Science, London WC2A 2AE, UK h.naci@lse.ac.uk.; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Davis C; Department of Global Health and Social Medicine, King's College London, London, UK., Savović J; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West) at University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Higgins JPT; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West) at University Hospitals Bristol NHS Foundation Trust, Bristol, UK.; National Institute for Health Research Bristol Biomedical Research Centre, Bristol, UK., Sterne JAC; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; National Institute for Health Research Bristol Biomedical Research Centre, Bristol, UK., Gyawali B; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Cancer Research Institute, Queen's University at Kingston, Kingston, Ontario, Canada., Romo-Sandoval X; Department of Health Policy, London School of Economics and Political Science, London WC2A 2AE, UK., Handley N; Department of Global Health and Social Medicine, King's College London, London, UK., Booth CM; Cancer Research Institute, Queen's University at Kingston, Kingston, Ontario, Canada.

المصدر: BMJ (Clinical research ed.) [BMJ] 2019 Sep 18; Vol. 366, pp. l5221. Date of Electronic Publication: 2019 Sep 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Drug Approval/*methods , Neoplasms/*drug therapy , Randomized Controlled Trials as Topic/*methods, Bias ; Cross-Sectional Studies ; Drug and Narcotic Control ; Humans ; Research Design ; Research Report